# professional-source-gap-managed-gate-v1 Review

## Review Notes

- Completed locally. The change refines gate policy without hiding source limitations.
- `professional_source_gap_prioritization` still exposes EROK and SPY details.
- `professional_source_gap_attention` is no longer opened for the current fixture state where EROK is already blocked from professional decision use and paper validation.
- A dedicated regression test confirms an unguarded source blocker still opens attention.
- No recommendation scoring, benchmark, portfolio position, thesis, paper outcome, or broker/order path changed.

## Verification

- Passed: `PYTHONPATH=src /opt/homebrew/bin/python3.13 -m unittest tests.test_frontend_live_adapter` (`73 tests`).
- Passed: `cd apps/web && npm run typecheck`.
- Passed: `PYTHONPATH=src /opt/homebrew/bin/python3.13 -m compileall -q src tests`.
- Passed: `bash scripts/verify_project_execution_roadmap.sh`.
- Passed: `PYTHONPATH=/Users/woody/ai/agent-work-harness/src /opt/homebrew/bin/python3.13 -m awh verify --repo . --task professional-source-gap-managed-gate-v1`.
- Passed on EC2: pulled commit `657e95d`, ran compileall, `tests.test_frontend_live_adapter` (`73 tests`), `npm run typecheck`, and `npm run build`.
- Passed on EC2: restarted `stockanalysis-frontend-api.service` and `stockanalysis-web.service`; both were `active`.
- Passed on EC2: `/api/data-health` no longer includes `professional_source_gap_attention`; `professional_source_gap_prioritization.attention_required=false`, first gap `EROK`, and the first gap remains blocked from professional decision use and paper validation.
- Passed on EC2: `/data-health` renders managed-source-limit Korean copy and no raw `professional source gap attention` chip.

## Remaining

- The source limitation remains real. EROK still needs a future periodic filing or a dedicated prospectus/pro-forma parser before it can be used for professional company-financial decisions.
